• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

DigitalTradz's Profile

Avatar:

Membership:

Premium

Person Marks:

4

Total Posts:

545

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

03/06/2017 7:49:38 AM

Personal info

Recent Articles

• Boehringer Ingelheim Unveils Promising Cancer Trials at ASCO 2025
• Soleno Therapeutics Advances in Treating Hyperphagia for PWS
• Embracing Peace Through Collective Prayer and Support
• Understanding Distribution Sources for Cohen & Steers' Fund
• Innovative Cancer Research from RWJBarnabas Health Surfaces
• Abeona's ZEVASKYN Breakthrough: A New Hope for DEB Patients
• Silvercorp Exhibits Strong Fiscal Year-End Performance 2025
• Univest Securities Completes $5 Million Offering for WORK Medical Tech
• Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
• Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
• Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
• Daktronics Engages at Leading Investor Conference This May
• Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
• IMUNON Seeks to Withdraw Registration Amid Growth Plans
• Abcourt Mines Inc. Reports Solid Third Quarter Progress
• PDS Biotech Shares Positive Results for Versamune® HPV Treatments
• Servotronics' Proxy Contest Conclusion and Upcoming Meeting
• Haivision to Unveil Financial Insights for Q2 Fiscal 2025
• M-tron Industries, Inc. Announces Upcoming Investor Meeting
• Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
• Investors Can Join Digimarc Corporation Class Action Today
• ImCheck Therapeutics Showcases Promising AML Therapy Results
• Legend Biotech Reveals Significant Updates in Cancer Treatment
• ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
• Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
• Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
• Acceleware Ltd. Achieves Significant Progress in Q1 2025
• Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
• Petrus Resources Shares Success of Annual Meeting Outcomes
• Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
• Candel Therapeutics Advances Localized Prostate Cancer Treatment
• Adagene Showcases Promising Results for ADG126 in Cancer Trials
• Banco Comercial Português Highlights Key AGM Resolutions
• Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
• Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
• Accent Therapeutics Showcases Innovative Cancer Treatment Advances
• Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
• Ontario International Airport Sees Record Passenger Growth
• Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
• XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
• Servier Showcases Commitment to IDH-Mutated Cancer Research
• West Fraser Timber's Commitment to Sustainability in 2024
• Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
• Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
• Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
• COOFANDY Celebrates a Decade of Excellence with Major Awards
• Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
• Unlock Passive Income with PAIRMiner's Cutting-Edge Mining
• THOR Industries Prepares for Upcoming Q3 2025 Earnings Call
• Clear Blue Technologies Plans Corporate Update and Q1 2025 Report